22 results about "Treatment Setting" patented technology

Systems and methods implement algorithms for initializing medical devices, including by programming initial medical device settings. Further, systems and methods implement adaptive algorithms for changing medical device settings. Settings initialization algorithms can calculate the settings most likely to be applicable for the patient at-issue using databases of positive clinical outcomes and respective therapy settings for existing users. Settings adaptation algorithm are configured to update medical device therapy settings at one or more intervals including based on databases of positive clinical outcomes and respective therapy settings for existing users.

The present disclosure provides a device and a method for neuromodulation treatment. The neuromodulation device comprises a pulse generator to generate electrical pulses and at least one active electrode coupled to the pulse generator. The at least one active electrode has an electrically conductive surface configured to be attached to a leg of a patient. The at least one active electrode stimulates via the electrically conductive surface a nerve of the leg of the patient by the electrical pulses generated by the pulse generator. A control unit controls the pulse generator and sets at least one parameter of the generated electrical pulses. A response detector detects a response of the patient to the nerve stimulation and provides feedback on the detected response to the control unit. For the treatment the control unit determines a treatment setting by varying an initial setting of the at least one parameter of the generated electrical pulses until the detected response of the patient to the nerve stimulation is within a predetermined range.

In one embodiment, an implantable medical device (IMD) comprises: therapeutic circuitry for controlling delivery of a medical therapy to a patient; a processor for controlling the IMD according to executable code; wireless communication circuitry for conducting wireless communications; and memory for storing data and executable code, wherein the executable comprises code for causing the processor to (1) communicate with an external programming device to define therapeutic settings for operation of the IMD, (2) perform validation operations on one or more instances of therapeutic settings by determining whether a respective instance of therapeutic settings is accompanied by permanent validation data or temporary validation data, wherein the validation operations comprise analyzing temporary validation data against at least one key of a plurality of cryptographic keys stored by the IMD.

: A system for predicting tissue treatment settings and response of tissue is described. When executed by the processor, instructions cause the processor to: (a) receive measured nitric oxide (NO) tissue data from a personal healthcare device; (b) apply a trained computational model to predict an NO response, and based on the predicted NO response, predict tissue treatment settings; (c) compare the predicted treatment settings to a safety limit; (d) when the comparison of the predicted treatment settings is equal to or below the safety limit, update the predicted treatment settings and carrying out the tissue treatment at the predicted treatment settings; and (e) when the comparison of the prediction is greater than the safety limit, adjust the tissue treatment settings, update weights of the trained computational model, and repeat (c) through (e). A method and a tangible, non-transitory computer readable medium to make the predictions are also disclosed.

The present invention relates to methods for tuning treatment parameters in movement disorder therapy systems. The present invention further relates to a system for screening patients to determine viability as candidates for certain therapy modalities, such as deep brain stimulation (DBS). The present invention still further provides methods of quantifying movement disorders for the treatment of patients who exhibit symptoms of such movement disorders including, but not limited to, Parkinson's disease and Parkinsonism, Dystonia, Chorea, and Huntington's disease, Ataxia, Tremor and Essential Tremor, Tourette syndrome, stroke, and the like. The present invention yet further relates to methods of tuning a therapy device using objective quantified movement disorder symptom data acquired by a movement disorder diagnostic device to determine the therapy setting or parameters to be provided to the subject via his or her therapy device. The present invention also provides treatment and tuning remotely, allowing for home monitoring of subjects.

A programmer is configured to effect communication with, and programming of, an implantable medical device configured to deliver neurostimulation therapy. The programmer comprises a display, such as touch screen display, and a processor comprising memory and coupled to the display. An interface is coupled to the processor and configured to receive therapy settings data indicative of current therapy settings operative in the implantable medical device and any modifications made to the therapy settings by a patient. The processor is configured to determine if one or more therapy settings have been modified since the last interaction with the patient, and coordinate displaying of the current therapy settings, the one or more therapy settings modified by the patient, and a previous state of the one or more therapy settings modified by the patient on the display.

Disclosed is an exercise therapy control apparatus using a UI that includes a segment selection progress bar, comprising: a signal input device for receiving a point selection signal from a patient in a step of generating therapy for the patient by a robot; a display for displaying a therapy setting UI for selecting at least one segment in a therapy progress step; and a processor for performing a segment setting process in the therapy progress step by means of the therapy setting UI.

A method of acclimating a patient to a therapy and a system for carrying out such method. The method includes providing the patient with an initial step of a therapy set up program for the patient to perform and determining at least one step metric. The at least one step metric determined is: a stress level of the patient while performing the initial step, successful completion of the initial step, the time needed to complete the initial step, and / or the quantity of errors made while carrying out the initial step. The method further includes determining a subsequent step for the patient to perform immediately after the initial step based on the at least one step metric and providing the patient with the subsequent step.

A system and method of quantifying, maintaining and managing the functional status and / or therapy settings of an IMD based on code path metrics is disclosed. The codebase of device firmware modules may be instrumented to obtain tracing data and timing metrics data corresponding to different code paths that may be taken when a device subsystem or associated functionality is accessed or activated. Code path metrics of actual code paths may be analyzed to detect a deviation from baseline code path metrics and generate a corresponding graduated response.

A method of acclimating a patient to a therapy and a system for carrying out such method. The method includes providing the patient with an initial step of a therapy set up program for the patient to perform and determining at least one step metric. The at least one step metric determined is: a stress level of the patient while performing the initial step, successful completion of the initial step, the time needed to complete the initial step, and / or the quantity of errors made while carrying out the initial step. The method further includes determining a subsequent step for the patient to perform immediately after the initial step based on the at least one step metric and providing the patient with the subsequent step.

To provide a system and a method for automatically porting respiratory therapy settings to a novel respiratory therapy device.SOLUTION: A system is for performing processing which includes: receiving (i) input indicating a patient would like to port prescription therapy settings from a second respiratory therapy device to a first respiratory therapy device, and (ii) an identifier of the first respiratory therapy device; on the basis of a patient account ID associated with the patient, retrieving the prescription therapy settings of the patient from a prescription database; on the basis of the prescription therapy settings of the patient and the identifier of the first respiratory therapy device, determining whether or not the prescription therapy settings of the patient is effective for the first respiratory therapy device; and, when the prescription therapy settings of the patient is determined to be effective for the first respiratory therapy device, storing the prescription therapy settings of the patient in a memory of the first respiratory therapy device.SELECTED DRAWING: Figure 9

This application relates to a conveying system and a medical device control system applied in a diagnostic and treatment setting. The conveying system includes a conveying device and a track positioning line; the track positioning line connects at least one treatment room and at least one preparation room, wherein the conveying device moves along the track positioning line; the track positioning line consists of two basic positioning lines used to distinguish the direction of movement of the conveying device, wherein the first and second basic positioning lines have different morphological parameters. This application can improve diagnostic and treatment efficiency.

To provide a system that can collect data regarding the timing of cap removal and / or replacement from a medication dispensing device and can be used to determine treatment settings and / or treatment recommendations.SOLUTION: A pen cap 112, 122 for a medication delivery pen 110, 120 includes a piston-type detector mechanism. The piston-type detector mechanism includes an inner shell having at least a first open end into which the medication delivery pen can be inserted, a second end opposite the first end, a sidewall defined by an outer surface and an opposing inner surface, and a passageway extending from the outer surface to the inner surface. The sidewall extends between the first end and the second end, thereby defining a pen-receiving cavity therebetween. The piston-type detector mechanism further includes at least one switch and a translatable shaft at least partially disposed within the passageway.SELECTED DRAWING: Figure 1A

A programmer is configured to effect communication with, and programming of, an implantable medical device configured to deliver neurostimulation therapy. The programmer comprises a display, such as a touch display, and a processor comprising memory and coupled to the display. An interface is coupled to the processor and configured to receive therapy setting data indicative of current therapy settings operative in the implantable medical device and any modifications made to the therapy settings by a patient. The processor is configured to determine if one or more therapy settings have been modified since the last interaction with the patient and coordinate displaying of the current therapy settings, the one or more therapy settings modified by the patient, and a previous state of the one or more therapy settings modified by the patient on the display.

Hyperbaric oxygen therapy (HBOT) settings of gas mixture and pressure are established based on electroencephalography (EEG) readings from a human within a hyperbaric chamber. Specifically, brainwave readings are affected by the HBOT process, which are used to improve the medical benefits achieved through the HBOT therapy regime, especially for treatments of cognitive disorders and neurological conditions detectable via EEG. In embodiments, HBOT settings are altered until a treated human is placed in a healing state, where cognition is enhanced. This healing state is quantitively definable through analysis of Alpha, Beta, Delta, and Theta EEG readings taken while in chamber and while outside the chamber. Once settings are determined to achieve a healing state of positive cognition, HBOT sessions can be conducted at pressure and gas mixture settings to ensure the healing state is achieved for each session. Post treatment analysis can be performed to determine EEG quantifiable improvements achieved.

Techniques for automatic device configuration are disclosed herein. In some embodiments, the techniques involve receiving patient data by one or more processors of a cloud-based server device. The techniques further involve obtaining, by the cloud-based server device, and based on the patient data, a value of a total daily dose of insulin for the specific patient. The techniques further involve automatically selecting, by the cloud-based server device, before the medical device has been set up to deliver insulin to the specific patient, a therapy configuration for the medical device. The techniques further involve determining, by the cloud-based server device, a set of therapy settings for the selected therapy configuration for the specific patient based upon the value of the total daily dose. The techniques further involve automatically configuring, via a non-medical device, the medical device with the set of therapy settings in a startup mode.

A system for predicting tissue treatment settings and response of tissue is described. When executed by the processor, instructions cause the processor to: (a) receive measured nitric oxide (NO) tissue data from a personal healthcare device; (b) apply a trained computational model to predict an NO response, and based on the predicted NO response, predict tissue treatment settings; (c) compare the predicted treatment settings to a safety limit; (d) when the comparison of the predicted treatment settings is equal to or below the safety limit, update the predicted treatment settings and carrying out the tissue treatment at the predicted treatment settings; and (e) when the comparison of the prediction is greater than the safety limit, adjust the tissue treatment settings, update weights of the trained computational model, and repeat (c) through (e). A method and a tangible, non-transitory computer readable medium to make the predictions are also disclosed.

The invention discloses a method for relieving invasive memory of a mental disorder patient, and relates to the technical field of mental health. The invention discloses a method for relieving invasive memory of a mental disorder patient. The method comprises the following steps of patient inquiry and baseline evaluation, graph selection, individualized masking threshold determination, unconscious activation and cognitive intervention, dynamic adjustment, rotation and repetition, treatment setting and evaluation. According to the method, the wound memory network is automatically activated on the subconsciousness level by presenting the wound masking picture which cannot be consciously perceived by the patient, so that the key step that the patient must actively recall the wound image in a painful manner in the prior art is thoroughly replaced, and a cognitive task (Tetris) is linked to obtain a cognitive result. And the interference on the unconsciously activated memory traces is realized. In the whole treatment process, the patient does not need to consciously face wounds, secondary psychological injury is fundamentally avoided, the safety and compliance of treatment are remarkably improved, and the problem of high exit rate caused by pain in the process of a traditional therapy is expected to be solved.

A method of customizing an energy-based aesthetic treatment includes obtaining image data identifying a treatment area and a tissue-contacting part of a treatment device. The method further includes selecting an anatomical classification criterion based on a type of energy modality used for said treatment. The method further includes determining, by analyzing the image data using the anatomical classification criterion, a plurality of treatment sub-areas that are differentiated based on a measurable or observable property of an anatomical characteristic which varies across regions of tissue in the treatment area. The method further includes determining, while said treatment is being performed, a current treatment sub-area of the treatment area that is actively being treated or targeted for treatment, and adjusting one or more treatment settings of the treatment device based on the measurable or observable property of the anatomic characteristic of a region of tissue in the current treatment sub-area.

The invention provides a method, equipment, a medium and a program product for characterizing drugs based on a whole genome. A new adjuvant therapy result model is constructed on the basis of a method for representing drugs by using gene expression correlation, and a construction method, equipment, a medium and a program product for predicting the new adjuvant therapy result model are provided. The invention provides a method, equipment, a medium and a program product for predicting a new adjuvant therapy result in an application stage, and relates to the field of intelligent medical treatment. The new adjuvant therapy result model serves as a biological information deep learning method, drug characterization and transcriptome are fused, more accurate oncology can be achieved, and the treatment decision process of breast cancer new adjuvant therapy is enhanced. Drug characterization and biomics data are integrated to represent a novel method for simulating interaction of drugs and tumors, a digital organ platform is provided for accurate oncology, and the method can be widely applied to different treatment environments and various cancer types.

An aerosol containment enclosure is used to isolate an air mass immediately surrounding a patient known or suspected to have a disease which may be transmitted through the air. The enclosure cooperates with a patient support apparatus (PSA). In embodiments, a flexible rod supports a substantially aerosol impermeable covering and is connected to the PSA. The enclosure may be semi-rigid and collapsible to a predetermined collapsed shape. The enclosure may be rapidly erected around a patient in an ambulance or other treatment setting. Embodiments of couplers provide compatibility with a wide diversity of sized and shaped PSAs. One coupler is connectable to the PSA with a coupler end exposed along a frame and upwardly extensible toward a PSA surface. A connector extends from the flexible rod and engages with the coupler end. The coupler may be longitudinally or laterally adjustable along the PSA.